PsychedelicNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) Announces Partnership with Leading Educational Platform to Provide Psychedelic Therapy Training
May 3, 2021
Tryp Therapeutics (CSE: TRYP), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, has entered a master service agreement with Fluence, an expertise-driven educational platform that provides professional training in psychedelic therapy and psychedelic integration for psychiatrists, psychotherapists, social workers, and other healthcare practitioners. The partnership will provide design and training for the psychotherapeutic component of Tryp’s clinical trial activities and will strengthen Tryp’s capability to plan and implement clinical trials. The agreement will also enhance the company’s ability to make the most of the information gathered. Fluence has specific expertise in psychedelic clinical trials and is the leading provider of psychotherapeutic training for health professionals who administer psychedelic compounds to patients. In the announcement, Fluence noted that it looks forward to working with Tryp in conducting important research that could be used to develop treatment options for patients suffering from chronic pain, eating disorders and other conditions. Tryp’s collaboration with Fluence will be initially focused on supporting Tryp’s upcoming Phase 2a clinical trial for eating disorders. “In the fast-moving arena of psychedelic therapies, Fluence has established themselves as the leader in psychotherapy design and training,” said Tryp president and chief science officer Jim Gilligan, PhD, in the press release. “Psychotherapy is an essential component of the effective administration of our innovative psilocybin formulations for the chronic pain and eating disorder indications that we are pursuing. Fluence’s experience with training hundreds of clinicians combined with the training protocol they are creating with Tryp will help create a safer and more effective treatment protocol for our clinical trials and ultimately for patients suffering from these conditions.”
To view the full press release, visit https://ibn.fm/wG5kp
About Tryp Therapeutics Inc.
Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and safety profiles for the treatment of rare and other diseases with unmet medical needs. Tryp’s psilocybin-for-neuropsychiatric disorders, or PFN(TM) (“PFN”), program is focused on the development of synthetic psilocybin as a new class of drug for the treatment of certain neuropsychiatric-based disorders. Tryp’s lead PFN drug candidate is TRP-8802 for the treatment of fibromyalgia, a chronic pain syndrome estimated to affect more than five million people in the United States. The company is also preparing to initiate a phase 2a clinical study for eating disorders in partnership with the Dr. Jennifer Miller at the University of Florida. In addition to its PFN program, Tryp is developing TRP-1001, an oral formulation of razoxane for the treatment of soft-tissue sarcoma. Soft-tissue sarcomas are a rare and diverse group of tumors that account for about 1% of all cancers in adults and 7% in children. Based on the prevalence of soft-tissue sarcomas in the United States, Tryp believes it is a rare disease and that TRP-1001 should qualify for orphan drug status. For more information about the company, please visit www.TrypTherapeutics.com.
NOTE TO INVESTORS: The latest news and updates relating to Tare available in the company’s newsroom at https://ibn.fm/TRYPF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]
PsychedelicNewsWire is part of the InvestorBrandNetwork.
More News
Madhya Pradesh adds 8.19 lakh voters since final SIR roll, electorate rises to 5.48 crore
Madhya Pradesh has added 8.19 lakh voters in the draft electoral roll under the Special Summary Revision. This increase has resulted in a total electorate of nearly 5.48 crore voters in the state. The Electoral Commission has invited claims and objections until December 11, with the final roll to be published on January 4, 2027. The age group of 30-39 represents the highest number of voters among the registered electors.
Lakshya Sen Creates History, Becomes 1st Indian To Reach Kumamoto Masters Japan Final
Fresh off his HYLO Open title, Sen came through 21-12, 15-21, 21-11 in a 70-minute encounter to book his place in the summit clash.
'Jewel of India': Rahul Gandhi pays homage to former PM Jawaharlal Nehru
Congress leader Rahul Gandhi honored Jawaharlal Nehru on his birth anniversary, calling him a guiding force for India. He stated that Nehru's ideals of democracy, diversity, and equality remain vital for the nation. Priyanka Gandhi Vadra emphasized Nehru's revolutionary spirit and ongoing relevance in protecting democratic values. Mallikarjun Kharge recalled Nehru's contributions to India's social, political, and economic foundations after independence.
Five sectors account for 83% of India's record October merchandise export surge: Report
Exports from the five sectors - engineering goods, petroleum products, electronic goods, gems and jewellery, and organic and inorganic chemicals - increased 59.4 per cent to USD 34.37 billion in October, compared with USD 21.56 billion in the corresponding month last year.
Indian envoy Kwatra slams USCIRF over Sharjeel Imam remarks, says panel has 'no locus standi'
Vinay Mohan Kwatra, India's Ambassador to the United States, criticized USCIRF for its comments on Sharjeel Imam. He stated the commission has no authority to judge Indian citizens' constitutional rights. Kwatra's remarks follow USCIRF's characterization of Imam's detention as related to his advocacy for religious freedom. Sharjeel Imam has been detained since January 2020 for allegedly inciting communal violence.
Indian envoy Kwatra slams USCIRF over Sharjeel Imam remarks, says panel has 'no locus standi'
Vinay Mohan Kwatra, India's Ambassador to the United States, criticized USCIRF for its comments on Sharjeel Imam. He stated the commission has no authority to judge Indian citizens' constitutional rights. Kwatra's remarks follow USCIRF's characterization of Imam's detention as related to his advocacy for religious freedom. Sharjeel Imam has been detained since January 2020 for allegedly inciting communal violence.
Cleaner, smarter, big data: the PLA’s bet on ‘sunshine’ military recruitment
The Chinese military is mining big data to get better recruits and stamp out corruption in the march towards its centenary next year. As part of an overhaul called “end-to-end sunshine” recruitment, the People’s Liberation Army has been commanded to use data-driven systems across the the enlistment process to build a military “focused on war readiness”. The orders came this month from the general offices of the Central Military Commission and State Council and mark a renewed push to eradicate...
Chhath Puja 2026: 2,500 cops deployed across Noida, security tightened at 146 ghats
Gautam Buddha Nagar Police have established extensive security and traffic arrangements for the upcoming Chhath Puja celebrations. Approximately 2,500 civil police personnel and Provincial Armed Constabulary companies have been deployed to ensure safety. The festival will occur at 146 locations, with special arrangements at 13 key sites expected to see large crowds. Devotees will perform rituals over four days, starting with Nahay Khay and concluding with Usha Arghya.
Chhath Puja 2026: 2,500 cops deployed across Noida, security tightened at 146 ghats
Gautam Buddha Nagar Police have established extensive security and traffic arrangements for the upcoming Chhath Puja celebrations. Approximately 2,500 civil police personnel and Provincial Armed Constabulary companies have been deployed to ensure safety. The festival will occur at 146 locations, with special arrangements at 13 key sites expected to see large crowds. Devotees will perform rituals over four days, starting with Nahay Khay and concluding with Usha Arghya.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.